title: Inflammatory, insulin resistance metabolic markers and pancreatic cancer: quo vadis? [corrected].
authors.affiliation: Department of Surgery, Division of Public Health Sciences, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.
authors.forename: Adetunji T
authors.initials: AT
authors.lastname: Toriola
authors.forename: Ryan C
authors.initials: RC
authors.lastname: Fields
mesh_terms: D050154:Adiposity; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D007333:Insulin Resistance; D009765:Obesity / Q000276:immunology / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000276:immunology / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D018836:Inflammation Mediators
keywords: IGF-I; IGFBP-3; adiponectin; insulin resistance; metabolism; pancreatic cancer; risk; survival